Genetic testing in Hungary

The goal is to offer the country’s eye doctors and other specialists the wide portfolio of Asper’s test. Currently working in close collaboration with Optovision Ltd. Asper Biotech has the goal of reaching the Hungarian eye doctors offering them diagnostics solutions that are enhanced by our partner’s advancing knowledge in eye disease genetics. Co-operation with internet medicine network and wide partner network enables to reach the goals quickly and efficiently bringing on stronger brand presence for Asper and a comprehensive medical product market for Optovision.

Optovision is widening its network of clinics and doctors over all medical areas that Asper’s tests cover.

Asper at ESHG 2010

Several new innovative genetic tests and services will be launched on the market this year. At the European Human Genetics Conference on 12-15 June 2010 in Gothenburg, Sweden Asper’s representatives will provide wider and more attractive products than ever before. We are glad to meet our partners and clients in Asper Biotech (#B218) and Genorama (#B134) boxes.

About Us

New panels in Hematology testing menu

Neutropenia panel for 26 genes and severe combined immunodeficiency panel for 44 genes are now available through Asper Biogene.

Updates in Dermatology testing menu

We have added new genes to the Oculocutaneous Albinism and Ichthyosis gene panels.

Hereditary ataxia testing menu

We have upgraded our hereditary ataxia testing menu. In addition to the comprehensive panel, repeat expansion analysis for SCA1, SCA2, SCA3 and SCA6 is also available. 

Antidepressants PGx test

Asper Biogene has launched a new pharmacogenetic test – Antidepressants PGx – for assessing metabolic response to antidepressant medications.

SNHL and Hypothyroidism and Thyroid Hormone Resistance panels.

New genes have been added to Sensorineural Hearing Loss and Hypothyroidism and Thyroid Hormone Resistance panels.

News in Asper Pharmacogenetics

Asper Pharmacogenetics testing menu has been updated with Contraceptives + HRT PGx test. Malignant hyperthermia panel now includes the STAC3 gene.